0 citations
HELIOS-A: RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
Journal of the American College of Cardiology2022Vol. 79(9), pp. 302–302
Citations Over Time
Alejandra González‐Duarte, David Adams, Ivailo Tournev, Mark Taylor, Teresa Coelho, Violaine Planté‐Bordeneuve, John L. Berk, Julian D. Gillmore, Soon-Chai Low, Yoshiki Sekijima, Laura Obici, Chongshu Chen, Prajakta Badri, Seth Arum, Joshua R. Vest, Michael Polydefkis
Related Papers
- → HELIOS-A: RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY(2022)8 cited
- → Two cases of late onset familial amyloid polyneuropathy with a Glu61Lys transthyretin variant(2018)4 cited
- → Structurally abnormal transthyretin causing familial amyloidotic polyneuropathy in Sweden(1987)28 cited
- → Aged onset of amyloidosis caused by transthyretin gene mutations(2003)
- → Neuropathological features in familial amyloid polyneuropathy caused by transthyretin E61K variant(2017)